211 related articles for article (PubMed ID: 26818779)
1. Effective treatment by glycolic acid peeling for cutaneous manifestation of familial generalized acanthosis nigricans caused by FGFR3 mutation.
Ichiyama S; Funasaka Y; Otsuka Y; Takayama R; Kawana S; Saeki H; Kubo A
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):442-5. PubMed ID: 26818779
[TBL] [Abstract][Full Text] [Related]
2. Effects of glycolic acid peeling on the cutaneous manifestation of generalized acanthosis nigricans caused by FGFR3 mutation: A report of one sporadic and two familial cases.
Ichiyama S; Kubo A; Matayoshi T; Saeki H; Funasaka Y
J Dermatol; 2017 Oct; 44(10):e250-e251. PubMed ID: 28620983
[No Abstract] [Full Text] [Related]
3. Familial acanthosis nigricans with p.K650T FGFR3 mutation.
Fukuchi K; Tatsuno K; Matsushita K; Kubo A; Ito T; Tokura Y
J Dermatol; 2018 Feb; 45(2):207-210. PubMed ID: 29068064
[TBL] [Abstract][Full Text] [Related]
4. Acanthosis nigricans in a Chinese girl with FGFR3 K650 T mutation: a case report and literature review.
Fu J; Zhao Y; Wang T; Zhang Q; Xiao X
BMC Med Genet; 2019 Jan; 20(1):8. PubMed ID: 30635042
[TBL] [Abstract][Full Text] [Related]
5. Familial acanthosis nigricans due to K650T FGFR3 mutation.
Berk DR; Spector EB; Bayliss SJ
Arch Dermatol; 2007 Sep; 143(9):1153-6. PubMed ID: 17875876
[TBL] [Abstract][Full Text] [Related]
6. Familial acanthosis nigricans with the FGFR3 mutation: Differences of pigmentation between male and female patients.
Yasuda M; Morimoto N; Shimizu A; Toyoshima T; Yokoyama Y; Ishikawa O
J Dermatol; 2018 Nov; 45(11):1357-1361. PubMed ID: 30168875
[TBL] [Abstract][Full Text] [Related]
7. Autosomal dominant familial acanthosis nigricans caused by a C-terminal nonsense mutation of FGFR3.
Tahara U; Yasuda M; Yamada Y; Aoki S; Sato S; Amagai M; Kubo A
J Hum Genet; 2021 Aug; 66(8):831-834. PubMed ID: 33580140
[TBL] [Abstract][Full Text] [Related]
8. FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature.
Blomberg M; Jeppesen EM; Skovby F; Benfeldt E
Dermatology; 2010; 220(4):297-305. PubMed ID: 20453470
[TBL] [Abstract][Full Text] [Related]
9. Familial hypochondroplasia and acanthosis nigricans with FGFR3 K650T mutation.
Cossiez Cacard MA; Coulombe J; Bernard P; Kaci N; Bressieux JM; Souchon PF; Motte J; Legeai-Mallet L; Hadj-Rabia S; Eschard C
J Eur Acad Dermatol Venereol; 2016 May; 30(5):897-8. PubMed ID: 25809207
[No Abstract] [Full Text] [Related]
10. Hypochondroplasia and Acanthosis nigricans: a new syndrome due to the p.Lys650Thr mutation in the fibroblast growth factor receptor 3 gene?
Castro-Feijóo L; Loidi L; Vidal A; Parajes S; Rosón E; Alvarez A; Cabanas P; Barreiro J; Alonso A; Domínguez F; Pombo M
Eur J Endocrinol; 2008 Sep; 159(3):243-9. PubMed ID: 18583390
[TBL] [Abstract][Full Text] [Related]
11. Comparison of efficacy and safety of tretinoin 0.05% and glycolic acid peeling 70% in axillary and neck lesions of acanthosis nigricans: A single-blinded, randomized trial.
Ghiasi M; Samii R; Tootoonchi N; Balighi K; Heidari S
J Cosmet Dermatol; 2024 Jun; 23(6):2090-2096. PubMed ID: 38362706
[TBL] [Abstract][Full Text] [Related]
12. Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation.
Couser NL; Pande CK; Turcott CM; Spector EB; Aylsworth AS; Powell CM
Am J Med Genet A; 2017 Apr; 173(4):1097-1101. PubMed ID: 28181399
[TBL] [Abstract][Full Text] [Related]
13. Mosaic mutations in FGFR3 and FGFR2 are associated with naevoid acanthosis nigricans or RAVEN (round and velvety epidermal naevus).
Larsabal M; Cogrel O; Caumont C; Jegou MH; Taïeb A; Morice-Picard F
Br J Dermatol; 2019 Jan; 180(1):201-202. PubMed ID: 30117157
[No Abstract] [Full Text] [Related]
14. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
[TBL] [Abstract][Full Text] [Related]
15. [Acanthosis nigricans in children and Crouzon syndrome].
Lagaude M; Barreau M; Jokic M; Gerard M; DiRocco F; Hadj-Rabia S; Dompmartin A; Verneuil L
Ann Dermatol Venereol; 2014 Nov; 141(11):685-8. PubMed ID: 25442473
[TBL] [Abstract][Full Text] [Related]
16. Acanthosis nigricans and hypochondroplasia in a child with a K650Q mutation in FGFR3.
Berk DR; Boente Mdel C; Montanari D; Toloza MG; Primc NB; Prado MI; Bayliss SJ; Pique LM; Schrijver I
Pediatr Dermatol; 2010; 27(6):664-6. PubMed ID: 21510009
[TBL] [Abstract][Full Text] [Related]
17. Acanthosis nigricans in a child with mild osteochondrodysplasia and K650Q mutation in the FGFR3 gene.
Leroy JG; Nuytinck L; Lambert J; Naeyaert JM; Mortier GR
Am J Med Genet A; 2007 Dec; 143A(24):3144-9. PubMed ID: 18000903
[TBL] [Abstract][Full Text] [Related]
18. Topical sirolimus therapy for epidermal nevus with features of acanthosis nigricans.
Dodds M; Maguiness S
Pediatr Dermatol; 2019 Jul; 36(4):554-555. PubMed ID: 30983034
[TBL] [Abstract][Full Text] [Related]
19. [Nevoid acanthosis nigricans or RAVEN (rounded and velvety epidermal nevus): three cases].
Petit A; Lemarchand-Venencie F; Pinquier L; Lebbe C; Bourrat E
Ann Dermatol Venereol; 2012 Mar; 139(3):183-8. PubMed ID: 22401682
[TBL] [Abstract][Full Text] [Related]
20. Crouzon syndrome with acanthosis nigricans and prominent diffuse hyperpigmentation associated with gain-of-function A391E mutation in FGFR3 gene.
Kariya H; Nakano H; Ishii N; Kaimi Y; Imai K; Nakanishi Y; Kunihiro N; Fukai K
J Dermatol; 2020 Dec; 47(12):e451-e452. PubMed ID: 32860240
[No Abstract] [Full Text] [Related]
[Next] [New Search]
